Academic literature on the topic 'Overactive Urinary Bladder'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Overactive Urinary Bladder.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Overactive Urinary Bladder"
ABREU, Glícia Estevam de, Eneida Regis DOURADO, Danielle de Novais ALVES, Milly Queiroz de ARAUJO, Natália Souza Paes MENDONÇA, and Ubirajara BARROSO JUNIOR. "FUNCTIONAL CONSTIPATION AND OVERACTIVE BLADDER IN WOMEN: A POPULATION-BASED STUDY." Arquivos de Gastroenterologia 55, suppl 1 (August 21, 2018): 35–40. http://dx.doi.org/10.1590/s0004-2803.201800000-46.
Full textZwierzyńska, Anna. "Overactive bladder." Journal of Education, Health and Sport 11, no. 7 (July 15, 2021): 116–23. http://dx.doi.org/10.12775/jehs.2021.11.07.010.
Full textHwang, Ye-Chae, Hye-Jin Lee, Hye-Min Heo, Gyu-Ri Jeon, Seung-Yeon Cho, Seong-Uk Park, Chang-Nam Ko, and Jung-Mi Park. "Clinical Report of Baliao Electroacupuncture Treatment on a Stroke Patient Suffering from a Neurogenic Overactive Bladder." Journal of Internal Korean Medicine 43, no. 1 (March 31, 2022): 90–103. http://dx.doi.org/10.22246/jikm.2022.43.1.90.
Full textUtama, Bobby Indra, Widayat Widayat, and Berriandi Arwan. "The Incidence of Overactive Bladder (OAB) in KIA Poly Patients at Pauh Health Center in Padang City Using Overactive Bladder Symptoms Score (OABSS)." JOURNAL OBGIN EMAS 3, no. 2 (November 27, 2019): 55–62. http://dx.doi.org/10.25077/aogj.3.2.55-62.2019.
Full textUtama, Bobby Indra, Widayat Widayat, and Berriandi Arwan. "The Incidence of Overactive Bladder in KIA Poly Patients at Pauh Health Center in Padang City Using Overactive Bladder Symptoms Score." JOURNAL OBGIN EMAS 3, no. 2 (December 12, 2019): 83–89. http://dx.doi.org/10.25077/aoj.3.2.83-89.2019.
Full textKostiuk, I., G. Chayka, and Yu Garnets. "The urethral closure function status in pregnant women suffering from overactive bladder syndrome." HEALTH OF WOMAN, no. 9(135) (November 30, 2018): 66–69. http://dx.doi.org/10.15574/hw.2018.135.66.
Full textRogowski, Artur, Maria Krowicka-Wasyl, Ewa Chotkowska, Tomasz Kluz, Andrzej Wróbel, Dominika Berent, Paweł Mierzejewski, et al. "Psychiatric History and Overactive Bladder Symptom Severity in Ambulatory Urogynecological Patients." Journal of Clinical Medicine 10, no. 17 (September 3, 2021): 3988. http://dx.doi.org/10.3390/jcm10173988.
Full textTrivedi, Sameer, Pranab Patnaik, Yashpal Ramole, Faiz Ahmed Khan, Ragini Srivastava, and Udai Shankar Dwivedi. "Role of Serum and Urinary Biomarkers in Evaluation and Management of Patients With Overactive Bladder." Clinical Medicine Insights: Urology 12 (January 2019): 117956111986490. http://dx.doi.org/10.1177/1179561119864907.
Full textKuzmin, Igor V., Margarita N. Slesarevskaya, and Viktoria V. Romikh. "Overactive bladder, inflammation and urinary tract infection: pathogenetic parallels." Urology reports (St. - Petersburg) 14, no. 1 (March 29, 2024): 65–79. http://dx.doi.org/10.17816/uroved627461.
Full textSubhan, Sana, Syed Imran Ahmad, Muhammad Hammad Ali Mithani, Aftab Ahmed Mirza Baig, Muhammad Kashif, and Muhammad Arif Siddiqui. "Effects of transcutaneous tibial nerve stimulation for overactive bladder symptoms in adults: A randomized controlled trial." Rehabilitation Journal 07, no. 03 (September 30, 2023): 36–41. http://dx.doi.org/10.52567/trehabj.v7i03.7.
Full textDissertations / Theses on the topic "Overactive Urinary Bladder"
Moonat, Shweta. "Investigation of neural correlates of bladder control using functional magnetic resonance imaging (fMRI) in patients with overactive bladder (OAB)." Master's thesis, Temple University Libraries, 2008. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/217452.
Full textM.S.E.E.;
Overactive bladder (OAB) is considered to be a disorder of the urinary bladder and is defined by the International Continence Society Terminology Committee as "urgency, with or without urge incontinence, usually with frequency and nocturia". There is some preliminary evidence using functional magnetic resonance imaging (fMRI) that the brain response to bladder filling in OAB patients is abnormal. The purpose of this research is to determine whether there are Central Nervous System (CNS) differences in modulating bladder function that contribute to, or are themselves the cause of the symptoms in OAB patients. We further investigated the pharmacological fMRI changes
Temple University--Theses
Omae, Kenji. "Gait speed and overactive bladder in the healthy community-dwelling super elderly-The Sukagawa Study." Kyoto University, 2020. http://hdl.handle.net/2433/245838.
Full textCorreia, Sofia Gonçalves. "Urinary incontinence and overactive bladder in the non-institutionalized Portuguese population: national survey and methodological issues." Master's thesis, Faculdade de Medicina da Universidade do Porto, 2008. http://hdl.handle.net/10216/21944.
Full textCorreia, Sofia Gonçalves. "Urinary incontinence and overactive bladder in the non-institutionalized Portuguese population: national survey and methodological issues." Dissertação, Faculdade de Medicina da Universidade do Porto, 2008. http://hdl.handle.net/10216/21944.
Full textSchoendorfer, Niikee, Nita Sharp, Tracey Seipel, Alexander G. Schauss, and Kiran D. K. Ahuja. "Urox containing concentrated extracts of Crataeva nurvala stem bark, Equisetum arvense stem and Lindera aggregata root, in the treatment of symptoms of overactive bladder and urinary incontinence: a phase 2, randomised, double-blind placebo controlled trial." BIOMED CENTRAL LTD, 2018. http://hdl.handle.net/10150/627047.
Full textLeiria, Luiz Osório 1983. "Estudo morfofuncional e molecular do baixo trato urinário de camudongos diabéticos." [s.n.], 2010. http://repositorio.unicamp.br/jspui/handle/REPOSIP/308913.
Full textDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-17T02:28:29Z (GMT). No. of bitstreams: 1 Leiria_LuizOsorio_M.pdf: 1930744 bytes, checksum: 214d355861ca93277cceba03b993e869 (MD5) Previous issue date: 2010
Resumo: As disfunções do baixo trato urinário estão entre as complicações mais comumente associadas ao diabetes mellitus, e incluem urgência miccional, alterações da freqüência e incontinência urinária, hiperatividade e hipertrofia da bexiga, tornando complexos os procedimentos diagnósticos e terapêuticos. O mediador primário para a contração do músculo liso detrusor é a acetilcolina (Ach), sendo suas ações mediadas, principalmente, pelos receptores muscarínicos do subtipo M3 e M2, principalmente o subtipo M3. O receptor P2X1, ativado pelo trifosfato de adenosina (ATP), também participa da contração do detrusor; porém, com menor importância. Ambos promovem a contração através da mobilização de Ca2+ citosólico, seja pela formação de inositol trifosfato (IP3), seja pelo influxo de Ca2+ extracelular via canais de Ca2+ tipo L. Além destes mecanismos, os receptores M3 podem desencadear resposta contrátil independente da concentração de Ca2+ citosólico, através da sensibilização ao mesmo, a qual ocorre, principalmente, pela ação da enzima Rho-kinase. A despeito de sua grande relevância na contração da bexiga, até o presente, poucos estudos abordaram as alterações na homeostase do Ca2+ celular resultantes do diabetes mellitus. Além disso, a contribuição da uretra para a cistopatia diabética ainda é pouco compreendida e estudada. O objetivo deste trabalho foi investigar as alterações funcionais, morfológicas e moleculares do baixo trato urinário em camundongos C57BL/6 com diabetes induzida por estreptozotocina, bem como compreender o papel da uretra na fisiopatologia desta desordem. Para tanto, realizamos os seguintes experimentos: 1) análise histomorfométrica da bexiga; 2) estudo cistométrico; 3) concentração-resposta ao agonista muscarínico carbacol (na ausência e na presença do Y27632 ou nifedipina), ao agonista purinérgico ?,?-metileno ATP, cloreto de potássio (KCl) e ao cloreto de cálcio (CaCl2), assim como curvas freqüência-resposta à estimulação elétrica (1-32 Hz, 80 V, 10 segundos) em detrusor isolado, e montado em banho para órgão preenchido com solução de Krebs Henseleit; 4) curvas concentração-resposta ao agonista ?1-adrenérgico fenilefrina, bem como de relaxamento ao nitroprussiato de sódio, tadalafil e Bay 41-2272, em anéis de músculo liso de uretra; 6) expressão de RNAm de receptores muscarínicos M2 e M3, purinérgicos P2X1 e canais de Ca2+ tipo L em detrusor. Os animais diabéticos apresentaram aumento do peso da bexiga, da espessura da parede e do volume da mesma em relação aos camundongos controle. A densidade de tecido neural também foi maior no grupo diabético, enquanto nenhuma alteração foi verificada em relação à densidade de músculo liso e de colágeno. O estudo cistométrico revelou aumento da capacidade e complacência da bexiga nos animais diabéticos, assim como maior amplitude das contrações de micção, aumento da freqüência de micção e de contrações involuntárias. Estes ainda exibiram aumento da pressão intravesical pós-miccional, evidenciando uma perda da eficiência da micção. A contratilidade do detrusor isolado de camundongos diabéticos se mostrou maior em resposta ao carbacol, ?,?-metileno ATP, KCl, CaCl2 e estímulo elétrico. Para avaliar o papel dos canais de Ca2+ tipo L e da rho-quinase no aumento da resposta contrátil ao carbacol, realizamos curvas ao carbacol na presença do bloqueador de canal de Ca2+ tipo L, nifedipina (3 nM) ou do inibidor da rho-quinase, Y27632 (1 µM). A pré-incubação com nifedipina preveniu o aumento da contração no grupo diabético, enquanto na presença do Y27632 não houve redução significativa das contrações em ambos os grupos. A expressão de RNAm de receptores M3 foi significativamente maior no grupo diabético em comparação com o grupo controle, enquanto não foram observadas alterações significativas na expressão de receptores M2 e P2X1. Os camundongos diabéticos exibiram aumento significativo da expressão de RNAm de canais de Ca2+ tipo L. As curvas concentração-resposta em músculo liso de uretra revelaram aumento da contração em resposta à fenilefrina e redução do relaxamento ao doador de óxido nítrico (NO), nitroprussiato de sódio (SNP), no grupo diabético. Em suma, nossos dados mostram que o aumento da contração do músculo detrusor em camundongos diabéticos é devido ao aumento do influxo de Ca2+ extracelular através dos canais de Ca2+ tipo L e ao aumento da expressão de receptores muscarínicos M3. Além disso, o aumento da resistência mecânica da uretra resultou em perda da eficiência do esvaziamento da bexiga associada à hiperatividade da mesma
Abstract: Bladder dysfunction is among the most common and incapacitating complications of diabetes mellitus. The diabetes related lower urinary tract symptoms (LUTS) include overactive bladder, incontinence, urgency, frequency increase and bladder hypertrophy. Acethylcholine (ACh) is the main neurotransmitter responsible for the detrusor smooth muscle contraction, acting mainly at the muscarinic M2 and M3 subtypes. P2X1, through ATP stimuli, also contribute to void contractions. Both M3 and P2X1 activation triggers citosolic Ca2+ mobilization by triphosphate inositol (IP3) formation or extracellular Ca2+ influx through L-type Ca2+ channels. Activation of M3 receptors can also elicit contractile response through Ca2+ concentration-independent pathways. Despite the great importance of Ca2+ handling/homeostases to receptor-mediated bladder contractions, its contribution to diabetic cistopathy has been little studied. In addition, the contribution of urethra in diabetic cistopathy remains poorly comprehended. The present study was designed to evaluate the functional, structural and molecular alterations of detrusor and urethral smooth muscles (DSM) in streptozotocin-induced diabetic mice. The following experiments were performed: 1) Hystomorfometric measurements; 2) Cystometric study; 3) Contractile responses to the muscarinic agonist carbachol (in the absence and in the presence of nifedipine or Y27632), purinergic agonist ?,?-methylene ATP, KCl, CaCl2 and electrical field stimulation (EFS, 1-32 Hz, 80 V, 10 sec) in detrusor strips mounted in organ baths containing Krebs-Henseleit solution; 4) Concentration-response curves to the ?1-adrenergic agonist phenylefrine were performed in isolated rings of urethral smooth muscle and relaxant curves to sodium nitroprusside (SNP), tadalafil and Bay 41-2272; 5) Expression of mRNA of muscarinic receptors M3 and M2, purinergic P2X1 receptors and L-type Ca2+ channels in detrusor by real-time RT-PCR. Histomorfometric analysis revealed increased bladder weight, volume and wall thickness. Neural tissue density was also higher in diabetic mice, whereas smooth muscle and collagen density were not modified in both groups. Cistometric study revealed increases in bladder capacity and compliance in diabetic group, as well as higher peak pressure, micturition frequency and frequency of non-void contractions. Diabetic mice exhibited enhanced post-void pressure, indicating a decrease in bladder emptying efficiency. Detrusor contractile responses to carbachol, ?,?-methylene ATP, KCl, CaCl2 and EFS were significantly higher in diabetic mice. In order to evaluate the role of L-type Ca2+ channels and rho-kinase in the detrusor hypercontractility, contraction curves to carbacol were performed in the presence of L-type Ca2+ channel blocker nifedipine (3 nM) or the rho-kinase inhibitor Y27632 (1 µM). Pre-incubation with nifedipine prevented the increased carbachol-induced detrusor contractions seen in the diabetic mice, while Y27632 did not significantly affect the detrusor contractions in both groups. Levels of mRNA of M3 receptor and L-type Ca2+ channels were significantly increased in diabetic animals, while M2 and P2X1 mRNA expression were not modified in both groups. Concentration-response curves in urethral smooth muscle revealed an increased contractile response to phenylefrine, and a reduction on the relaxant responses to nitric oxide donor, sodium nitroprusside (SNP), in diabetic group, indicating an enhanced urethral resistance by diabetes. In conclusion, our data shows that the overactive detrusor in diabetes is likely to be due an increase in extracellular Ca2+ influx through L-type Ca2+ channels and an enhanced M3 muscarinic expression. Moreover, the higher urethral mechanical resistance result in decrease of the bladder emptying efficiency in diabetic mice associated to detrusor overactivity
Mestrado
Mestre em Farmacologia
Tsai, Kathleen. "The Impact of Urinary Incontinence Severity on Direct Healthcare Utilization, Work Productivity, and Clinical Events among Individuals with Overactive Bladder." Thesis, The University of Arizona, 2013. http://hdl.handle.net/10150/306998.
Full textSeth, J. "Tibial Nerve Stimulation for the management of overactive bladder and the measurement of urinary neurotrophins as a biomarker of response to treatment." Thesis, University College London (University of London), 2017. http://discovery.ucl.ac.uk/1566640/.
Full textPalma, Thaís Figueiredo 1984. "Influência da idade, do índice de massa corporal e de antecedentes obstétricos nos sintomas da síndrome da bexiga hiperativa em mulheres no menacme = Influence of age, body mass index and obstetric history in the symptoms of overactive bladder in women in menacme." [s.n.], 2014. http://repositorio.unicamp.br/jspui/handle/REPOSIP/312545.
Full textTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-24T12:04:58Z (GMT). No. of bitstreams: 1 Palma_ThaisFigueiredo_D.pdf: 5188121 bytes, checksum: 3443d8a70ab4644713a51d88beb4d20c (MD5) Previous issue date: 2014
Resumo: Introdução: A Síndrome da Bexiga Hiperativa (BH) é definida pela ICS (International Continence Society) como urgência urinária, acompanhada ou não por incontinência e frequentemente associada ao aumento da frequência urinária e noctúria. Objetivo: O objetivo do estudo foi verificar a influência da idade, do índice de massa corporal (IMC) e de antecedentes gestacionais nos sintomas de bexiga hiperativa em mulheres no menacme. Pacientes e Métodos: No total foram avaliados os questionários preenchidos por 1052 mulheres com idade entre 20 e 45 anos na região de Campinas. Foi utilizado o questionário ICIQ-OAB, uma ferramenta específica para bexiga hiperativa, em sua versão validada em Português e uma ficha de avaliação para dados demográficos e história médica, incluindo: idade, peso, altura, paridade e via de parto. Resultados: De modo geral, mulheres com idade entre 35 e 45 anos apresentaram escore do ICIQ-OAB significativamente maior do que todos os outros grupos (20 a 22; 23 a 27 e 38 a 34) (p<0.0001). Mulheres multíparas e primíparas apresentaram escore significativamente maior do que as nulíparas (p<0,001); e os sintomas não diferiram de acordo com a via de parto - vaginal ou cesárea (p=0.0074). Não foram encontradas diferenças significativas no escore entre os grupos de IMC (<18,5; 18,8 a 24,9; 25 a 29,9 e ? 30) (p=0,0066). Também foram encontradas diferenças significativas com relação ao incômodo causado pelos sintomas. Mulheres de 35 a 45 anos se sentem mais incomodadas do que os outros grupos com relação á frequência (p<0.0001), noctúria (p=0.0011), urgência (p=0.0015) e incontinência por urgência (p<0.0001). O incômodo causado pelos sintomas não diferiu entre os grupos de mulheres nulíparas, primíparas e multíparas (p=0,9363). As mulheres com IMC entre 25 e 29,9 apresentaram incômodo maior do que aquelas com IMC entre 18,5 e 24,9, com relação à incontinência por urgência (p=0,002). Conclusões: Na população estudada de mulheres no menacme, os sintomas de bexiga hiperativa são encontrados mais frequentemente e causam mais incômodo em mulheres com idade mais avançada, índice de massa corporal mais elevado e com histórico de pelo menos uma gestação
Abstract: Introduction: Overactive Bladder Syndrome (OAB) is defined by the ICS (International Continence Society) as urinary urgency, with or without urgency incontinence and frequently associated with increase of frequency and nocturia. Objectives: The aim of the study was to verify the influence of age, body mass index (BMI) and obstetric history in the symptoms of overactive bladder in premenopausal women. Patients and Methods: We analyzed a total of 1052 questionnaires that were filled out by women aged 20-45 in the area of Campinas, SP. We chose the ICIQ-OAB questionnaire, a tool that is specific for overactive bladder, in its Portuguese validated version and na assessment form with demographics and medical history, that included: age, weight, height, parity and mode of delivery (vaginal or cesarean). Results: Overall, women aged 35-45 presented higher scores than all other age groups (20 - 22; 23 - 27 and 38 - 34) (p<0.0001). Multiparous and primiparous women presented higher scores than nulliparous ones (p<0,001); and the symptoms did not differ according to mode of delivery ¿ vaginal or cesarean (p=0.0074). No significant differences were found between the BMI groups - <18,5; 18,8 - 24,9; 25 - 29,9 and ? 30 - (p=0,0066). We also found differences regarding symptom bother. Women aged 35-45 were more bothered than all other groups regarding frequency (p<0.0001), nocturia (p=0.0011), urgency (p=0.0015) and urgency incontinence (p<0.0001). Symptom bother did not differ between nuliparous, primiparous and multiparous women (p=0,9363). Women with BMI 25 - 29,9 were more bothered by urgency incontinence than those with BMI 18,5 - 24,9 (p=0,002). Conclusions: In the premenopausal women population of this study, OAB symptoms were found more frequently and cause more bother in older women, with higher BMI and with history of at least one pregnancy
Doutorado
Fisiopatologia Cirúrgica
Doutora em Ciências
Silva, Renata Helena José. "Imipramina versus tratamento conservador em mulheres com síndrome da bexiga hiperativa." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2011. http://hdl.handle.net/10183/39663.
Full textOveractive Bladder Syndrome (SBH) is characterized by urinary urgency with or without incontinence, accompanied by frequency and nocturia. Treatment is initially clinical, aimed at relaxing the detrusor muscle with the use of anticholinergics, antispasmodics and antidepressants tricíclinos. Anticholinergics reduce the contractile activity of the detrusor muscle by blocking muscarinic receptors at the neuromuscular junction. Imipramine is a tricyclic antidepressant that has anticholinergic action and alpha-adrenergic indirect, relaxing muscles and increasing detrusor pressure intrauretral, reducing the frequency of urinary leakage, being a good alternative for Urgency Urinary Incontinence (IUU) and mixed urinary incontinence (IUM). OBJECTIVES: To validate Imipramine as an option for patients with SBH and to verify the occurrence and frequency of adverse effects. METHODS: A randomized crossover clinical trial, with women over 18 years with complaints of IUU or IUM treated at the Urogynecology Clinic of Hospital de Clinicas de Porto Alegre (HCPA). For an improvement of 71% in the imipramine group and 16% of perineal exercises, with "p" of 0.05 and a power of 80%, 19 patients are needed in each group (Epi-Info). Totaled an "n" of 38 patients, an estimated 20% loss. RESULTS AND CONCLUSIONS: 38 women were randomized, with 6 patients excluded. 32 patients underwent three months of conservative treatment and three months of use of imipramine. At the end of 6 months was performed statistical analysis. 24 patients maintained their use of medication after the study. There was no difference between groups regarding demographics, comorbidities, medication use, surgery, genital dystopias, presence of side effects with the medication, time of drug discontinuation and urinary loss pressure (VLPP). There was statistical difference in relation to the presence of uninhibited contractions (CNI) during urodynamic evaluation. Regarding the questionnaires, the use of imipramine showed an improvement of 16.8 times over the allocation when compared to a 2.1 times improvement in the conservative treatment. Regarding the General Health Perception (PGS), there was no statistical difference, but in relation to assessing the impact of incontinence (II), there was significant difference in the group treated with imipramine performed. Demonstrated to an improvement in urinary loss of 16, 3 times when compared to the beginning of the allocation. The analysis of the final score showed a statistical significance in the group's interaction with the type of treatment used in a given moment in time. In conclusion, as the only medication available in the Brazilian Public Health System (SUS) to treat this disease that affects a substantial number of women, since it proved to be safe in relation to the side and made statistically significant compared to conservative treatment, we can move to use it with caution, as a therapeutic option for today's most commonly used anticholinergic, oxybutynin. However, it is believed that more trials should be conducted with more patients and perhaps comparing imipramine with oxybutynin, because it is a reference for this pathology.
Books on the topic "Overactive Urinary Bladder"
R, Chapple Christopher, ed. Overactive bladder in clinical practice. London: Springer-Verlag London Ltd., 2012.
Find full textMacDiarmid, Scott A., Jacques Corcos, and John Heesakkers. Overactive bladder: Practical management. Chichester, West Sussex, UK: John Wiley & Sons, 2015.
Find full textEllsworth, Pamela. Questions & answers about overactive bladder. 2nd ed. Sudbury, Mass: Jones and Bartlett Publishers, 2009.
Find full textEllsworth, Pamela. Questions & answers about overactive bladder and urinary incontinence. Sudbury, Mass: Jones and Bartlett, 2006.
Find full textRosenberg, Matt T. Contemporary diagnosis and management of urinary incontinence and overactive bladder. Newtown, Pa: Handbooks in Health Care Co., 2012.
Find full textCorcos, Jacques, Scott MacDiarmid, and John Heesakkers. Overactive Bladder: Practical Management. Wiley & Sons, Incorporated, John, 2015.
Find full textCorcos, Jacques, Scott MacDiarmid, and John Heesakkers. Overactive Bladder: Practical Management. Wiley & Sons, Incorporated, John, 2015.
Find full textCorcos, Jacques, Scott MacDiarmid, and John Heesakkers. Overactive Bladder: Practical Management. Wiley & Sons, Limited, John, 2015.
Find full textBook chapters on the topic "Overactive Urinary Bladder"
Janes, Sophia, Sara M. Lenherr, and Anne P. Cameron. "Botulinum Toxin for Overactive Bladder." In Female Urinary Incontinence, 193–205. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-84352-6_11.
Full textParsons, Brian A., and Marcus J. Drake. "Animal Models in Overactive Bladder Research." In Urinary Tract, 15–43. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16499-6_2.
Full textSoligo, Marco, and Alessandro Giammò. "Overactive Bladder and Female Stress Urinary Incontinence." In Non-Neurogenic Bladder Dysfunctions, 87–95. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-57393-5_7.
Full textPesce, Francesco, and Maria Angela Cerruto. "Medical Treatment of Urinary Incontinence, Urinary Retention, and Overactive Bladder." In Pelvic Floor Disorders, 271–76. Milano: Springer Milan, 2010. http://dx.doi.org/10.1007/978-88-470-1542-5_33.
Full textPurohit, Rajveer S., and Jerry G. Blaivas. "Treatment of Overactive Bladder Refractory to Medications." In Minimally Invasive Therapy for Urinary Incontinence and Pelvic Organ Prolapse, 123–32. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0008-4_11.
Full textZullo, Marzio Angelo. "Sacral Nerve Modulation for Urinary Disorders: Overactive Bladder." In Electrical Stimulation for Pelvic Floor Disorders, 137–44. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-06947-0_11.
Full textAtiemo, Humphrey, and J. Quentin Clemens. "Managing Overactive Bladder and Urinary Incontinence in the Male." In Urological Men’s Health, 129–40. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-61779-900-6_13.
Full textRobinson, Dudley, and Linda Cardozo. "Pharmacological Treatment of Urinary Incontinence and Overactive Bladder: The Evidence." In Pelvic Floor Disorders, 351–63. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-40862-6_26.
Full textPeeker, Ralph. "Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, and Overactive Bladder." In Handbook of Clinical Gender Medicine, 428–37. Basel: KARGER, 2012. http://dx.doi.org/10.1159/000336449.
Full textWesterik-Verschuuren, Liesbeth, Marjolijn Lutke Holzik-Mensink, Marleen Wieffer-Platvoet, and Minke van der Velde. "Sexual Aspects of Pelvic Floor Disturbances/Disorders." In Midwifery and Sexuality, 185–95. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-18432-1_16.
Full textConference papers on the topic "Overactive Urinary Bladder"
Long, Rebecca A., Aron Parekh, and Michael S. Sacks. "Strain Induced Bladder Smooth Muscle Remodeling." In ASME 2007 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2007. http://dx.doi.org/10.1115/sbc2007-176289.
Full textCelik, Ismail B., Asaf Varol, Coskun Bayrak, and Jagannath R. Nanduri. "A One Dimensional Mathematical Model for Urodynamics." In ASME/JSME 2007 5th Joint Fluids Engineering Conference. ASMEDC, 2007. http://dx.doi.org/10.1115/fedsm2007-37647.
Full textChampaigne, Kevin D., Sarette N. Jenderny, and Jiro Nagatomi. "Electrophysiological Investigation of Hydrostatic Pressure Mechanotransduction by Urothelial Cell Lines." In ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53518.
Full textSilva, Ingrid Antunes da, Carlos Augusto Faria, Iris Cardoso de Pádua Terra, Raquel Luiz Queres, Guilherme da Silva Bueno, and Alice Ferreira de Almeida. "Impacto da noctúria na qualidade de vida geral e específica de mulheres atendidas em dois ambulatórios de uroginecologia do Sistema Único de Saúde: um estudo transversal." In 46º Congresso da SGORJ e Trocando Ideias XXV. Zeppelini Editorial e Comunicação, 2022. http://dx.doi.org/10.5327/jbg-0368-1416-2022132s1024.
Full textReports on the topic "Overactive Urinary Bladder"
Leonardo, Kevin, Doddy Hami Seno, Hendy Mirza, and Andika Afriansyah. Biofeedback Pelvic Floor Muscle Training and Pelvic Electrical Stimulation in Women with Overactive Bladder : A Systematic Review and Meta-analysis of Randomized Controlled Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, February 2022. http://dx.doi.org/10.37766/inplasy2022.2.0024.
Full textElenkov, Chavdar, Ivo Donkov, Marin Georgiev, and Krassimir Yanev. Comparative Analysis of Newly-developed Overactive Bladder after Surgery for Stress Urinary Incontinence in Women. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, October 2019. http://dx.doi.org/10.7546/crabs.2019.10.15.
Full textTravis, Amanda, Margaret Harvey, and Michelle Rickard. Adverse Childhood Experiences and Urinary Incontinence in Elementary School Aged Children. University of Tennessee Health Science Center, October 2021. http://dx.doi.org/10.21007/con.dnp.2021.0012.
Full text